Log In
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
Forgot your password?
Log In
Don't have an account? Sign Up Here
Join Us
Receive full access to our market insights, commentary, newsletters, breaking news alerts, and more.
I agree to TheMaven's
Terms
and
Policy
Sign Up
Already have an account? Login here
JIM CRAMER
INVESTING
PERSONAL FINANCE
RETIREMENT
CRYPTO
MARKETS
HOW-TO
VIDEO
FINANCIAL ADVISOR CENTER
TECHNOLOGY
Search
Trade with Jim Cramer 14 Days Free
Join the Action Alerts PLUS Community today!
SUBSCRIBE NOW
LATEST NEWS
INVESTING
iShares Silver Trust, Virgin Galactic, Viela Bio: 5 Stock Gainers for Monday
By Rob Lenihan
Feb 1, 2021 4:30 PM EST
PRESS RELEASES
New Analysis Of UPLIZNA® (inebilizumab-cdon) For Neuromyelitis Optica Spectrum Disorder (NMOSD) Published In Neurology Neuroimmunology & Neuroinflammation
By Business Wire
May 6, 2021 8:30 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Announces Elizabeth H.Z. Thompson As A Healthcare Businesswomen's Association 2021 Luminary
By Business Wire
May 6, 2021 8:00 AM EDT
PRESS RELEASES
HemoShear Therapeutics Advances Second Novel Drug Target Into Horizon Therapeutics Plc Early Discovery Pipeline For Gout
By PR Newswire
Apr 21, 2021 7:30 AM EDT
PRESS RELEASES
New Long-Term Data For UPLIZNA® (inebilizumab-cdon) In People Living With Neuromyelitis Optica Spectrum Disorder (NMOSD)
By Business Wire
Apr 16, 2021 8:30 AM EDT
PRESS RELEASES
New Integrated Data And Follow-up Outcomes From Two TEPEZZA® (teprotumumab-trbw) Pivotal Trials Published In The Lancet Diabetes & Endocrinology
By Business Wire
Apr 16, 2021 8:00 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Named One Of The Fortune 100 Best Companies To Work For®
By Business Wire
Apr 12, 2021 8:30 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc To Release First-Quarter 2021 Financial Results And Host Webcast On May 5, 2021
By Business Wire
Apr 8, 2021 8:00 AM EDT
PRESS RELEASES
RECIPE Randomized Controlled Trial Data Published In Arthritis & Rheumatology Show Higher Response Rates Using KRYSTEXXA® (pegloticase Injection) With The Immunomodulator Mycophenolate Mofetil
By Business Wire
Apr 7, 2021 8:00 AM EDT
PRESS RELEASES
New UPLIZNA® (inebilizumab-cdon) Data In People With Neuromyelitis Optica Spectrum Disorder (NMOSD) To Be Presented At The American Academy Of Neurology's 73rd Annual Meeting
By Business Wire
Apr 5, 2021 8:30 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc To Resupply Market With TEPEZZA® (teprotumumab-trbw) For The Treatment Of Thyroid Eye Disease (TED) Beginning In April
By Business Wire
Mar 30, 2021 7:30 AM EDT
PRESS RELEASES
Horizon Therapeutics And Chicago Cubs Announce Legacy Partnership
By Business Wire
Mar 29, 2021 10:05 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Launches The Horizon Prize With Massachusetts Institute Of Technology (MIT) Solve To Advance Solutions For The Rare Disease Community
By Business Wire
Mar 24, 2021 8:00 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Completes Acquisition Of Viela Bio, Inc.
By Business Wire
Mar 15, 2021 8:50 AM EDT
PRESS RELEASES
Horizon Therapeutics Plc Named Number One Best Workplace In Biopharma
By Business Wire
Mar 12, 2021 8:45 AM EST
PRESS RELEASES
Horizon Therapeutics Plc Named As One Of The Best Workplaces In Ireland
By Business Wire
Mar 11, 2021 3:00 AM EST
PRESS RELEASES
Horizon Therapeutics Plc To Present At The Cowen And Company 41st Annual Health Care Conference
By Business Wire
Feb 26, 2021 4:05 PM EST
PRESS RELEASES
Horizon Therapeutics Plc Shines A Light On Rare Disease With The Launch Of The #RAREis Photobooth To Benefit Make-A-Wish®
By Business Wire
Feb 25, 2021 4:05 PM EST
PRESS RELEASES
New Survey Assessment Finds Debilitating Impact Of Thyroid Eye Disease (TED) On Quality Of Life Continues Well Beyond Acute Disease Into Chronic Phase
By Business Wire
Feb 22, 2021 9:30 AM EST
PRESS RELEASES
(VIE Alert) Johnson Fistel Investigates Proposed Sale Of Viela Bio; Are Shareholders Getting A Fair Deal?
By PR Newswire
Feb 20, 2021 8:33 PM EST
PRESS RELEASES
Horizon Therapeutics Plc To Release Fourth-Quarter And Full-Year 2020 Financial Results And Host Webcast On Feb. 24, 2021
By Business Wire
Feb 3, 2021 8:00 AM EST
INVESTING
iShares Silver Trust, Virgin Galactic, Viela Bio: 5 Stock Gainers for Monday
By Rob Lenihan
Feb 1, 2021 4:30 PM EST
PRESS RELEASES
SHAREHOLDER ALERT: WeissLaw LLP Investigates Viela Bio, Inc.
By PR Newswire
Feb 1, 2021 3:12 PM EST
INVESTING
Viela Bio Spikes as Horizon Therapeutics Agrees to Acquire It for $3.5 Billion
By Vidhi Choudhary
Feb 1, 2021 10:21 AM EST
PRESS RELEASES
(VIE Alert) Johnson Fistel Investigates Proposed Sale Of Viela Bio; Are Shareholders Getting A Fair Deal?
By PR Newswire
Feb 1, 2021 9:36 AM EST
